By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Singapore genomics service firm AITBiotech announced it has licensed molecular assays developed by research institutes under Singapore's Agency for Science Technology and Research (A*STAR).

The assays were licensed from Exploit Technologies, the marketing and commercialization arm of A*STAR.
The agreement covers dengue/chikungunya multiplex detection kits and a Mycobacterium tuberculosis detection kit. The kits are used with PCR systems.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.